Navigation Links
Research network wins approximately £5.7 million to target human and animal diseases in Africa
Date:7/1/2009

of national preparedness for disease outbreaks across the human and animal health sectors from the Rockefeller Foundation, on which LIDC will also assist. The SACIDS secretariat is funded with money from Google.org.

LIDC's partnership with SACIDS is part of its larger effort to break down barriers between agriculture and health research to encourage an integrated approach to complex international development problems. LIDC helps to develop critical interdisciplinary cooperation for international development by developing research and training programmes between the University of London's six Bloomsbury Colleges (Birkbeck, Institute of Education, LSHTM, RVC, School of Oriental and African Studies, and The School of Pharmacy) and developing country institutions.

LIDC has a growing portfolio of inter-College and interdisciplinary working groups investigating topics including: emerging and zoonotic diseases, linkages between agriculture and health, access to medicines in developing countries, and Distance Learning for Development (DL4D).


'/>"/>

Contact: Guy Collender
guy.collender@lidc.bloomsbury.ac.uk
020-795-88260
London School of Hygiene & Tropical Medicine
Source:Eurekalert

Page: 1 2 3

Related biology news :

1. Research shows skeleton to be endocrine organ
2. Newly created cancer stem cells could aid breast cancer research
3. Dominant cholesterol-metabolism ideas challenged by new research
4. Researchers identify proteins involved in new neurodegenerative syndrome
5. Texas researchers and educators head for Antarctica
6. MGH researchers describe new way to identify, evolve novel enzymes
7. University of Pennsylvania researchers develop formula to gauge risk of disease clusters
8. University of Oregon researcher finds that on waters surface, nitric acid is not so tough
9. U of MN researchers discover noninvasive diagnostic tool for brain diseases
10. U of Minnesota researchers discover noninvasive diagnostic tool for brain diseases
11. Story ideas from the Journal of Lipid Research

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/4/2009)...ct. 23 GenVault Corporation, the l...for genomic discovery, medicine and identification...lt,s President and CEO, will be presenting at the ... 26th and 27th in La Jolla, CA. ,, During the p...f the company together with recent customer, techn...
(Date:11/4/2009)...Newswire/ -- Glencoe Software, Inc., the commercia...sortium ( http://openmicroscopy.org ), is proud ...ciety of Cell Biology,s exciting new project title...awarded a $2.5M stimulus grant through the Nationa... program, as part of the American Reinvestment and...
(Date:11/3/2009)...r labeling of fruit and vegetables is a new, paten...e laser beam is used to label, or "etch" informati...mmon sticker-type labels. The technology has been ...bles and is being used in New Zealand, Australia, ...ed in Asia, South Africa, Central and South Americ...
Breaking Biology News(10 mins):GenVault Corporation to Present at the 2009 BIOCOM Investor Conference 2Glencoe Software to Support the ASCB 'Stimulus Grant' to Build Virtual Image Library of the Cell 2Laser etching safe alternative for labeling grapefruit 2Madzone Marketing LLC Taps TransMedia Group to Provide Publicity Lift to Knife and Forklift 28TM 29 53445 1Madzone Marketing LLC Taps TransMedia Group to Provide Publicity Lift to Knife and Forklift 28TM 29 53445 2Jatropha Couple Oil Crop Cultivation Technology Commercially Released 13320 1Jatropha Couple Oil Crop Cultivation Technology Commercially Released 13320 2Jatropha Couple Oil Crop Cultivation Technology Commercially Released 13320 3Shire Reports Positive Results From First of Three Phase III Trials of velaglucerase alfa for Type 1 Gaucher Disease and Provides Important Updates on 4809 1Shire Reports Positive Results From First of Three Phase III Trials of velaglucerase alfa for Type 1 Gaucher Disease and Provides Important Updates on 4809 2Shire Reports Positive Results From First of Three Phase III Trials of velaglucerase alfa for Type 1 Gaucher Disease and Provides Important Updates on 4809 3Shire Reports Positive Results From First of Three Phase III Trials of velaglucerase alfa for Type 1 Gaucher Disease and Provides Important Updates on 4809 4Shire Reports Positive Results From First of Three Phase III Trials of velaglucerase alfa for Type 1 Gaucher Disease and Provides Important Updates on 4809 5
... available in French . , , PRINCE GEORGE, B.C. ...nister of Natural Resources, Dick Harris, Member o...nced that Canadas New Governments Mountain Pine Be...o help communities, including First Nations, deal ...cedented beetle infestation in British Columbia. ,...
...lice discovered about 50 tons of rotten meat on th... risk of rotten meat turning up in grocery stores ...ance of efficient food quality monitoring is clear...nable large numbers of samples to be analysed quic...order to make comprehensive monitoring a reality. ...
...information we put in our heads" The answer: a lot...,000 words. And then there are all the little deta...p in, the time we spilled orange juice on our test...equation (for some of us). , So where do we put i...wer would be easy: we would store memories as 0s a...
Other Biology News:Mountain pine beetle: Canada's new government delivers 2New method reveals substances on surfaces of any kind 2A balanced memory network 2
(Date:11/6/2009)...BROOK, N.Y., Nov. 6 BioS...opharmaceutical company developing first-in-class ...nancial results for the third quarter ended Septem..., in September of this year, the FDA,s Arthritis A...te of 12-0, the approval of XIAFLEX(TM) for the tr...
(Date:11/6/2009)... VIENNA, Austria, November 6 EUCOD...manufacturing, and marketing enzymes for the,chemi...nto a research,agreement with Bio Sidus, the leadi..., The agreement gives EUCODIS Bioscience exc...est - to Bio Sidus, proprietary collection of,psyc...
(Date:11/6/2009)...GARY, Nov. 6 /PRNewswire-FirstCall/ - Oncolytics B...r the "Company") today announced updated results f... patients with sarcomas metastatic to the lung in ...e Tissue Oncology Society Meeting held in Miami Be... presentation, entitled "A Phase II Study of Intra...
(Date:11/5/2009)...SPORTATION -- Gone hybrid . . . , Fuel economy...re now posted at the www.fueleconomy.gov web sit...nd maintains for the U.S. Department of Energy and... the top 10 vehicles on the best fuel economy list... MPG city; 48 highway). "This list proves that hyb...
Breaking Biology Technology:Reissue with Tables: BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 2Reissue with Tables: BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 3Reissue with Tables: BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 4Reissue with Tables: BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 5Reissue with Tables: BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 6EUCODIS Bioscience to Explore Novel Enzymatic Activities in Antarctic Bacteria Library From Bio Sidus 2Oncolytics Biotech(R) Inc. Collaborators Present Positive Phase II Sarcoma Trial Results at CTOS Annual Meeting 2Oncolytics Biotech(R) Inc. Collaborators Present Positive Phase II Sarcoma Trial Results at CTOS Annual Meeting 3November 2009 story tips from the US Department of Energy's Oak Ridge National Laboratory 2November 2009 story tips from the US Department of Energy's Oak Ridge National Laboratory 3
...harmaceuticals Founder and Senior Management Form ... Podiatry Markets, FAIRFIELD, N.J., May 13 Medim...t commenced operations. The newly-formed,Company, ...eam of the,former Bradley Pharmaceuticals (NYSE: ...ovative prescription products for the Dermatology ...
...TY, May 13 /PRNewswire-FirstCall/ - AEterna Zentar...armaceutical company focused on,endocrine therapy ...led,"Placebo-controlled dose-ranging Phase 2 study...trorelix in patients with symptomatic benign,prost...ication in an,upcoming issue of the European Urolo...
... and TUCSON, Ariz., May 12 ,University-affiliated ...,crucial in creating opportunities for sustainable...s the globe. Experts in park development,will gath...the best,practices and emerging trends in maximizi...echnology development., BioParks 2008, a joint m...
Other Biology Technology:Medimetriks Pharmaceuticals, Inc. Begins Operations 2AEterna Zentaris: Article on Phase 2 Trial with Cetrorelix in BPH to be Published in European Urology Journal 2AEterna Zentaris: Article on Phase 2 Trial with Cetrorelix in BPH to be Published in European Urology Journal 3AEterna Zentaris: Article on Phase 2 Trial with Cetrorelix in BPH to be Published in European Urology Journal 4AEterna Zentaris: Article on Phase 2 Trial with Cetrorelix in BPH to be Published in European Urology Journal 5AEterna Zentaris: Article on Phase 2 Trial with Cetrorelix in BPH to be Published in European Urology Journal 6University Research and Science Parks Create Sustainable Innovation 2
...e NOVOstar is an exciting product for cell-based k..., cell-based assays required the use of expensive ... for scientists in the assay development stage. Th...r cell-based assays as well as any other assay sui...
...e Digital Clamp One can operate as a Voltage Clamp... Clamp in electrophysiology research applications....ional analog equipment. • This amazing in...in the capabilities of Digital Signal Processing (...
Dispensing Bins from Terra Universal, Inc.
Agilent MSD Security ChemStation for GC and GC/MS from Agilent Technologies
Biology Products: